Recent Updates
Recently added Catalysts
QTI Positive Sentiment

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

Tuesday, August 4, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QT Imaging Holdings, Inc. has appointed Jason Dyer and Dave Reinhart as Vice Presidents of Regional Sales for the East and West, respectively. This strategic move aims to enhance the company's direct U.S. commercial efforts for its Breast Acoustic CT Scanner. The appointments are expected to accelerate the adoption of this innovative, radiation-free imaging technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of experienced sales executives to boost strategy.
  • Focus on innovative, radiation-free imaging technology.
  • Expansion of direct U.S. commercial strategy for breast health.

Full Press Release Details

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today advanced the direct U.S. commercial strategy for its Breast Acoustic CT™ Scanner with the appointment of Jason Dyer as Vice President Regional Sales East and Dave Reinhart as Vice President Regional Sales West. Both executives joined QT Imaging in July 202

Frequently Asked Questions

What is the Breast Acoustic CT Scanner?

The Breast Acoustic CT Scanner is an innovative, radiation-free imaging technology designed for breast health management.

Who are the new executives at QT Imaging?

Jason Dyer is the Vice President of Regional Sales East, and Dave Reinhart is the Vice President of Regional Sales West.

What is QT Imaging's goal with these appointments?

The goal is to accelerate the adoption of the Breast Acoustic CT Scanner in the U.S. market.

When did the new executives join QT Imaging?

Both executives joined QT Imaging in July 2023.

ShareAdd on Google
Tags: QTI Viatris Investor Conferences Healthcare QT Imaging breast health radiation-free imaging medical device
Last updated: Aug 4, 2026

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~10 mo
Medium dilution risk